Aurobindo obtains FDA approval for generic PathocilDicloxacillin sodium capsules are indicated for the treatment of infections caused by penicillinase-producing staphylococci, which have demonstrated susceptibility to the drug. Camber debuts generic Vesicare Solifenacin succinate tablets are used to treat symptoms of overactive bladder, such as frequent or urgent urination and incontinence (urine leakage). AllianceRx Walgreens Pharmacy achieves reaccreditation from ACHC ACHC accreditation occurs every three years and will be effective for AllianceRx Walgreens Pharmacy specialty pharmacy until Sept. 15, 2025. Camber debuts generic Samsca Generic Samsca is used to treat hyponatremia, low levels of sodium in your blood, in people with heart failure and certain hormonal imbalances. U.S. District Court rules in favor of Merck in sitagliptin phosphate patent lawsuit Sitagliptin is an active ingredient in Januvia, Janumet and Janumet XR. Akorn to pay $7.9M to resolve allegations of fraudulent billing Akorn caused Medicare Part D to pay for three Akorn generic drugs that were no longer eligible for Medicare coverage. Novartis to petition U.S. Supreme Court to uphold validity of Gilenya dosing regimen patent Novartis said that it intends to vigorously defend the validity of the patent and is considering all available options. Coherus BioSciences to launch Lucentis biosimilar Cimerli is the first and only FDA-approved biosimilar interchangeable with Lucentis (ranibizumab injection). Upsher-Smith expands partnership with Appco The collaboration is part of Upsher-Smith’s effort to grow its portfolio of products through strategic partnerships and product acquisitions. Hikma intros 2 injectables The company is offering bortezomib for injection 3.5 mg and ulvestrant injection 250 mg/5 ml. First Previous 74 75 76 77 78 Next Last
